Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Living Donors | 10 | 2022 | 636 | 1.660 |
Why?
|
Kidney Transplantation | 14 | 2022 | 4214 | 1.210 |
Why?
|
Nephrectomy | 7 | 2021 | 1016 | 0.960 |
Why?
|
Tissue and Organ Harvesting | 5 | 2019 | 377 | 0.890 |
Why?
|
Lymphedema | 6 | 2023 | 524 | 0.730 |
Why?
|
Tissue Donors | 7 | 2022 | 2314 | 0.680 |
Why?
|
Lymphatic Vessels | 4 | 2023 | 358 | 0.590 |
Why?
|
Population Groups | 1 | 2017 | 211 | 0.530 |
Why?
|
Tissue and Organ Procurement | 7 | 2021 | 944 | 0.530 |
Why?
|
Carcinoma, Transitional Cell | 4 | 2023 | 800 | 0.510 |
Why?
|
Pain, Postoperative | 6 | 2024 | 1720 | 0.500 |
Why?
|
Cultural Diversity | 1 | 2017 | 365 | 0.440 |
Why?
|
Kidney Failure, Chronic | 5 | 2017 | 2470 | 0.440 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2023 | 2275 | 0.420 |
Why?
|
Lymph Node Excision | 6 | 2024 | 1303 | 0.390 |
Why?
|
Comprehension | 1 | 2017 | 617 | 0.390 |
Why?
|
Prostatectomy | 4 | 2024 | 1956 | 0.350 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3763 | 0.320 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11345 | 0.300 |
Why?
|
Burnout, Professional | 3 | 2021 | 702 | 0.290 |
Why?
|
Personal Satisfaction | 3 | 2019 | 643 | 0.260 |
Why?
|
Internet | 1 | 2017 | 3078 | 0.240 |
Why?
|
Prostate-Specific Antigen | 3 | 2024 | 2529 | 0.240 |
Why?
|
Lymphocele | 1 | 2024 | 19 | 0.230 |
Why?
|
Mastectomy | 4 | 2021 | 1832 | 0.230 |
Why?
|
Insurance, Health | 1 | 2016 | 2501 | 0.220 |
Why?
|
Motor Vehicles | 2 | 2015 | 281 | 0.220 |
Why?
|
Peritoneum | 1 | 2024 | 224 | 0.210 |
Why?
|
Gastric Bypass | 2 | 2023 | 826 | 0.210 |
Why?
|
Breast Neoplasms | 8 | 2023 | 21029 | 0.200 |
Why?
|
Obesity, Morbid | 2 | 2023 | 1287 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2022 | 3985 | 0.190 |
Why?
|
Mammaplasty | 2 | 2021 | 1240 | 0.180 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2022 | 187 | 0.180 |
Why?
|
Tissue Transplantation | 1 | 2021 | 128 | 0.180 |
Why?
|
Rectal Diseases | 1 | 2021 | 144 | 0.180 |
Why?
|
Renal Insufficiency | 2 | 2018 | 820 | 0.170 |
Why?
|
Pelvic Floor | 1 | 2021 | 138 | 0.170 |
Why?
|
Colonic Diseases | 1 | 2021 | 200 | 0.170 |
Why?
|
Video Recording | 2 | 2015 | 955 | 0.170 |
Why?
|
Liver Transplantation | 2 | 2022 | 2325 | 0.170 |
Why?
|
Penile Neoplasms | 1 | 2021 | 162 | 0.170 |
Why?
|
Pelvis | 1 | 2024 | 743 | 0.170 |
Why?
|
Lipectomy | 1 | 2020 | 112 | 0.160 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2943 | 0.160 |
Why?
|
Organ Transplantation | 2 | 2021 | 1150 | 0.160 |
Why?
|
Tracheotomy | 1 | 2019 | 167 | 0.150 |
Why?
|
Humans | 64 | 2024 | 760613 | 0.150 |
Why?
|
Surgical Procedures, Operative | 2 | 2022 | 1913 | 0.150 |
Why?
|
Surgery Department, Hospital | 1 | 2019 | 177 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 530 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1723 | 0.140 |
Why?
|
Random Allocation | 2 | 2019 | 2394 | 0.140 |
Why?
|
Gastroplasty | 1 | 2019 | 157 | 0.140 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 656 | 0.140 |
Why?
|
Cystectomy | 4 | 2023 | 697 | 0.140 |
Why?
|
Fear | 2 | 2018 | 1462 | 0.140 |
Why?
|
Waiting Lists | 2 | 2022 | 763 | 0.140 |
Why?
|
Muscle Strength | 1 | 2021 | 619 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 353 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2021 | 495 | 0.140 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 575 | 0.130 |
Why?
|
Postoperative Complications | 4 | 2024 | 15679 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3530 | 0.130 |
Why?
|
Urinary Bladder | 4 | 2023 | 1166 | 0.130 |
Why?
|
Quality of Life | 8 | 2023 | 13308 | 0.130 |
Why?
|
Models, Educational | 1 | 2019 | 373 | 0.130 |
Why?
|
Drug Prescriptions | 2 | 2024 | 1673 | 0.130 |
Why?
|
Patient Discharge | 3 | 2024 | 3474 | 0.130 |
Why?
|
Subthalamic Nucleus | 1 | 2018 | 193 | 0.130 |
Why?
|
Decision Making | 3 | 2019 | 3925 | 0.130 |
Why?
|
Drug Utilization | 1 | 2022 | 1195 | 0.130 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7475 | 0.130 |
Why?
|
Axilla | 3 | 2023 | 626 | 0.130 |
Why?
|
Surgical Flaps | 1 | 2024 | 1669 | 0.120 |
Why?
|
Male | 34 | 2024 | 359718 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39262 | 0.120 |
Why?
|
Hospitals, Teaching | 1 | 2019 | 1166 | 0.120 |
Why?
|
Automobile Driving | 1 | 2019 | 438 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2023 | 1152 | 0.110 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2001 | 0.110 |
Why?
|
Middle Aged | 27 | 2024 | 220359 | 0.110 |
Why?
|
Emotions | 3 | 2023 | 2734 | 0.110 |
Why?
|
Thoracic Surgery | 1 | 2020 | 725 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1031 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2024 | 80345 | 0.110 |
Why?
|
Adult | 25 | 2024 | 220007 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1238 | 0.110 |
Why?
|
Public Opinion | 1 | 2017 | 481 | 0.110 |
Why?
|
Aged | 22 | 2024 | 169143 | 0.110 |
Why?
|
Health Expenditures | 2 | 2016 | 2362 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.100 |
Why?
|
Body Image | 1 | 2018 | 635 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2016 | 1677 | 0.100 |
Why?
|
Female | 31 | 2024 | 391246 | 0.100 |
Why?
|
Consensus | 1 | 2022 | 3113 | 0.100 |
Why?
|
Fatigue | 1 | 2019 | 1544 | 0.100 |
Why?
|
Attitude to Health | 2 | 2020 | 2029 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2148 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1579 | 0.100 |
Why?
|
Laparoscopy | 1 | 2024 | 2147 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2022 | 1005 | 0.100 |
Why?
|
Lymphography | 2 | 2022 | 188 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7818 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5508 | 0.090 |
Why?
|
Alcoholism | 1 | 2022 | 1961 | 0.090 |
Why?
|
Massachusetts | 3 | 2019 | 8803 | 0.090 |
Why?
|
Indocyanine Green | 2 | 2023 | 236 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1175 | 0.090 |
Why?
|
Internship and Residency | 2 | 2021 | 5870 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2018 | 820 | 0.090 |
Why?
|
Affect | 1 | 2018 | 1480 | 0.090 |
Why?
|
Cost of Illness | 1 | 2019 | 1940 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3202 | 0.080 |
Why?
|
Patient Preference | 1 | 2017 | 922 | 0.080 |
Why?
|
Prognosis | 6 | 2022 | 29661 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3200 | 0.080 |
Why?
|
Arm | 2 | 2023 | 583 | 0.080 |
Why?
|
Gastrectomy | 2 | 2023 | 679 | 0.070 |
Why?
|
Upper Extremity | 2 | 2023 | 661 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2642 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2138 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2023 | 64981 | 0.070 |
Why?
|
Altruism | 2 | 2021 | 204 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15686 | 0.070 |
Why?
|
Health Promotion | 2 | 2015 | 2207 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3164 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2332 | 0.070 |
Why?
|
Aftercare | 2 | 2022 | 916 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4279 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4312 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2018 | 2859 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2022 | 3618 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2023 | 11152 | 0.060 |
Why?
|
Workload | 2 | 2020 | 847 | 0.060 |
Why?
|
Prostate | 2 | 2022 | 1793 | 0.050 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 87809 | 0.050 |
Why?
|
United States | 6 | 2024 | 72448 | 0.050 |
Why?
|
Administration, Intravesical | 1 | 2022 | 92 | 0.050 |
Why?
|
Young Adult | 7 | 2020 | 58748 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6853 | 0.050 |
Why?
|
Registries | 2 | 2016 | 8458 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40139 | 0.050 |
Why?
|
Epigastric Arteries | 1 | 2021 | 92 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2023 | 3486 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2021 | 71 | 0.050 |
Why?
|
Lymphatic System | 1 | 2022 | 254 | 0.050 |
Why?
|
Donor Selection | 1 | 2022 | 228 | 0.040 |
Why?
|
Marital Status | 1 | 2022 | 433 | 0.040 |
Why?
|
Coloring Agents | 1 | 2022 | 562 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2022 | 371 | 0.040 |
Why?
|
Accreditation | 1 | 2023 | 477 | 0.040 |
Why?
|
Religion and Medicine | 1 | 2021 | 160 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 555 | 0.040 |
Why?
|
Physical Endurance | 1 | 2021 | 363 | 0.040 |
Why?
|
Attitude to Death | 1 | 2021 | 400 | 0.040 |
Why?
|
New England | 1 | 2021 | 1050 | 0.040 |
Why?
|
Brain Death | 1 | 2021 | 356 | 0.040 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2019 | 189 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1791 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1039 | 0.040 |
Why?
|
Attitude | 1 | 2022 | 777 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2022 | 2852 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8556 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11713 | 0.030 |
Why?
|
Muscles | 1 | 2022 | 1581 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2021 | 510 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8552 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2020 | 539 | 0.030 |
Why?
|
SEER Program | 1 | 2022 | 1530 | 0.030 |
Why?
|
Death | 1 | 2021 | 678 | 0.030 |
Why?
|
Incidence | 3 | 2021 | 21391 | 0.030 |
Why?
|
Risk Factors | 5 | 2023 | 74333 | 0.030 |
Why?
|
Organ Size | 1 | 2021 | 2254 | 0.030 |
Why?
|
Automobile Driver Examination | 1 | 2015 | 25 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2022 | 1268 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 477 | 0.030 |
Why?
|
Kidney | 2 | 2022 | 7064 | 0.030 |
Why?
|
Survival Rate | 2 | 2022 | 12810 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2019 | 357 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9288 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1334 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1328 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1091 | 0.030 |
Why?
|
Goals | 1 | 2019 | 708 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2022 | 1501 | 0.030 |
Why?
|
Rhode Island | 1 | 2014 | 349 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1442 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 1037 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1440 | 0.030 |
Why?
|
Employment | 1 | 2019 | 1112 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6771 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1201 | 0.030 |
Why?
|
Trust | 1 | 2017 | 532 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2019 | 2659 | 0.020 |
Why?
|
Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2821 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2493 | 0.020 |
Why?
|
Graft Survival | 1 | 2021 | 3795 | 0.020 |
Why?
|
Operating Rooms | 1 | 2017 | 789 | 0.020 |
Why?
|
Informed Consent | 1 | 2017 | 1005 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3061 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2022 | 3185 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2893 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3364 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2299 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4815 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58980 | 0.020 |
Why?
|
Mass Screening | 1 | 2024 | 5422 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3928 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54306 | 0.020 |
Why?
|
Health Education | 1 | 2014 | 1049 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2684 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8022 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3531 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Reference Values | 1 | 2014 | 4925 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24102 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36286 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3718 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4319 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8055 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15286 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9278 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41337 | 0.010 |
Why?
|
Psychometrics | 1 | 2014 | 3051 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15840 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7805 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14494 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9278 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3711 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9716 | 0.010 |
Why?
|
Depression | 1 | 2020 | 8045 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10546 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22052 | 0.010 |
Why?
|
Anxiety | 1 | 2014 | 4538 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2014 | 4446 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18413 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20080 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81209 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25941 | 0.010 |
Why?
|
Animals | 1 | 2022 | 167960 | 0.010 |
Why?
|
Concepts
(244)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_